Philip Clingan

468 total citations
8 papers, 282 citations indexed

About

Philip Clingan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Philip Clingan has authored 8 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Philip Clingan's work include Colorectal Cancer Treatments and Studies (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). Philip Clingan is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Cancer Genomics and Diagnostics (2 papers). Philip Clingan collaborates with scholars based in Australia, United States and Germany. Philip Clingan's co-authors include Frances A. Shepherd, David R. Spigel, Martin Steins, Markus F. Renschler, Joachim von Pawel, Martin Reck, José Trigo, Wolfgang Schütte, Kristiaan Nackaerts and Jeffrey A. Bubis and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and HPB.

In The Last Decade

Philip Clingan

7 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip Clingan Australia 5 238 195 115 58 32 8 282
M. Flubacher United Kingdom 5 47 0.2× 50 0.3× 55 0.5× 57 1.0× 27 0.8× 8 187
Gianluca Businello Italy 10 116 0.5× 30 0.2× 60 0.5× 86 1.5× 81 2.5× 22 264
Krishnansu Tewari United States 7 58 0.2× 65 0.3× 66 0.6× 19 0.3× 39 1.2× 14 186
O Eremin United Kingdom 5 96 0.4× 41 0.2× 17 0.1× 27 0.5× 74 2.3× 10 181
Vincent E. Gaillard Switzerland 10 170 0.7× 74 0.4× 25 0.2× 75 1.3× 47 1.5× 21 348
S Silvestro Italy 6 230 1.0× 67 0.3× 17 0.1× 26 0.4× 33 1.0× 8 297
Francisco Quiles Spain 8 35 0.1× 90 0.5× 66 0.6× 34 0.6× 122 3.8× 15 281
Taichi Imamura Japan 5 160 0.7× 26 0.1× 46 0.4× 61 1.1× 29 0.9× 11 249
Carlos Aguado Spain 9 174 0.7× 25 0.1× 47 0.4× 115 2.0× 23 0.7× 41 241
Shreya Mehta Australia 8 117 0.5× 89 0.5× 21 0.2× 22 0.4× 52 1.6× 19 197

Countries citing papers authored by Philip Clingan

Since Specialization
Citations

This map shows the geographic impact of Philip Clingan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Clingan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Clingan more than expected).

Fields of papers citing papers by Philip Clingan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Clingan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Clingan. The network helps show where Philip Clingan may publish in the future.

Co-authorship network of co-authors of Philip Clingan

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Clingan. A scholar is included among the top collaborators of Philip Clingan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Clingan. Philip Clingan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Young, Rosemary, Paul N. Mainwaring, Philip Clingan, et al.. (2018). nab‐Paclitaxel plus gemcitabine in metastatic pancreatic adenocarcinoma: Australian subset analyses of the phase III MPACT trial. Asia-Pacific Journal of Clinical Oncology. 14(5). e325–e331. 4 indexed citations
2.
3.
Pawel, Joachim von, Robert M. Jotte, David R. Spigel, et al.. (2014). Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer. Journal of Clinical Oncology. 32(35). 4012–4019. 232 indexed citations
4.
Reni, Michele, Daniel D. Von Hoff, E. Gabriela Chiorean, et al.. (2013). CA19-9 Decrease and Kinetics in a Randomized Phase III Trial (MPACT) of Weekly Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Cancer. Annals of Oncology. 24. iv31–iv31. 2 indexed citations
5.
6.
Goel, Shom, Ehtesham Abdi, Craig Lewis, et al.. (2009). Phase II study of gemcitabine and docetaxel in combination for the treatment of metastatic breast cancer. Asia-Pacific Journal of Clinical Oncology. 5(1). 32–38. 1 indexed citations
7.
Clingan, Philip, et al.. (2006). REVIEW OF PATIENTS WITH PERITONEAL MALIGNANCY TREATED WITH PERITONECTOMY AND HEATED INTRAPERITONEAL CHEMOTHERAPY. ANZ Journal of Surgery. 76(3). 156–161. 30 indexed citations
8.
Talbot, Michael, Jonathan R. Clark, Philip Clingan, & David L. Morris. (2002). Gastroduodenal ulceration following hepatic arterial chemotherapy: the role of methylene blue endoscopy in the investigation of pain. HPB. 4(1). 29–34.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Flubacher Breakdown of academic impact, for papers by Gianluca Businello Breakdown of academic impact, for papers by Krishnansu Tewari Breakdown of academic impact, for papers by O Eremin Breakdown of academic impact, for papers by Vincent E. Gaillard Breakdown of academic impact, for papers by S Silvestro Breakdown of academic impact, for papers by Francisco Quiles Breakdown of academic impact, for papers by Taichi Imamura Breakdown of academic impact, for papers by Carlos Aguado Breakdown of academic impact, for papers by Shreya Mehta
Rankless by CCL
2026